The need for kidney transplantation in low- and middle-income countries in 2012: An epidemiological perspective

Transplantation

Volumn 99, Issue 3, 2015, Pages 476-481

  Muralidharan, Aditya ^a   White, Sarah ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; END STAGE RENAL DISEASE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE NEED; HUMAN; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LOW AND MIDDLE INCOME COUNTRY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIETY; THAILAND; TREATMENT RESPONSE; CULTURAL FACTOR; DEVELOPING COUNTRY; HEALTH; HEALTH CARE DELIVERY; HEALTH SERVICE; KIDNEY FAILURE, CHRONIC; LIVING DONOR; POVERTY; RENAL REPLACEMENT THERAPY; STATISTICS AND NUMERICAL DATA;

CULTURAL CHARACTERISTICS; DEVELOPING COUNTRIES; GLOBAL HEALTH; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; POVERTY; RENAL DIALYSIS; RISK FACTORS;

EID: 84930535958     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000657     Document Type: Review

References (37)

1. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guidelines for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3 (1): 4
2. Ayodele OE, Alebiosu CO,. Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis 2010; 17 (3): 215
3. The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014; 2 (8): 634
4. Lozano R, Naghavi M, Foreman K, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380 (9859): 2095
5. ESRD Patients in 2013. A Global Perspective. Fresenius Medical Care: Bad Homburg, Germany; 2013
6. Organización Nacional De Trasplantes (ONT). Global Observatory on Donation and Transplantation Organ Donation and Transplantation Activities, 2012. Madrid: 2013
7. White SL, Chadban SJ, Jan S, Chapman JR, Cass A,. How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ 2008; 86 (3): 229
8. Roels L, Kalo Z, Boesebeck D, Whiting J, Wight C,. Cost-benefit approach in evaluating investment into donor action: the German case. Transpl Int 2003; 16 (5): 321
9. Shimizu U, Saito S, Lings Y, Iino N, Kazama JJ, Akazawa K,. Cost-effectiveness achieved through changing the composition of renal replacement therapy in Japan. J Med Econ 2012; 15 (3): 444
10. Howard K, Salkeld G, White S, The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology 2009; 14 (1): 123
11. U.S. Renal Data System, USRDS 2013 Annual Report: atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013
12. Wolfe RA, Ashby VB, Milford EL, Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341 (23): 1725
13. Laupacis A, Keown P, Pus N, A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50 (1): 235
14. Dominguez J, Harrison R, Atal R,. Cost-benefit estimation of cadaveric kidney transplantation: the case of a developing country. Transplant Proc 2011; 43 (6): 2300
15. Perovic S, Jankovic S,. Renal transplantation vs hemodialysis: cost-effectiveness analysis. Vojnosanit Pregl 2009; 66 (8): 639
16. Tantivess S, Werayingyong P, Chuengsaman P, Teerawattananon Y,. Universal coverage of renal dialysis in Thailand: promise, progress, and prospects. Br Med J 2013; 346: f462
17. Ramachandran R, Jha V,. Kidney transplantation is associated with catastrophic out of pocket expenditure in India. PLoS One 2013; 8 (7): e67812
18. Bamgboye EL,. End-stage renal disease in sub-Saharan Africa. Ethn Dis 2006; 16 (2): S2. -5-9
19. Proceedings of The Global Alliance for Transplantation Workshop: July 2013, Durban, South Africa. The Transplantation Society; 2013
20. Alasia DD, Emem-Chioma P, Wokoma FS,. A single-center 7-year experience with end-stage renal disease care in Nigeria- A surrogate for the poor state of ESRD care in Nigeria and other sub-Saharan African countries: advocacy for a global fund for ESRD care program in sub-Saharan African countries. Int J Nephrol 2012; 2012: 639653
21. White SL, Hirth R, Mahillo B, The global diffusion of organ transplantation: trends, drivers and policy implications. Bull World Health Org 2014; 92 (11): 826
22. Nivatvongs S, Dhitavat V, Jungsangasom A, Thirteen years of the Thai red cross organ donation centre. Transplant Proc 2008; 40 (7): 2091
23. Shaheen FA, Souqiyyeh MZ,. How to improve organ donation in the MESOT countries. Ann Transplant 2004; 9 (1): 19
24. Atun R, Odorico Monteiro De Andrade L, Almeida G, Health-system reform and universal health coverage in Latin America. Lancet. October 15, 2014. [Epub ahead of print]
25. Mizraji R, Alvarez I, Palacios RI, Organ donation in Latin America. Transplant Proc 2007; 39 (2): 333
26. Participants in the International Summit on Transplant T, Organ Trafficking Convened by the Transplantation S, International Society of Nephrology in Istanbul TAM. The Declaration of Istanbul on organ trafficking and transplant tourism. Transplantation 2008; 86 (8): 1013
27. Stevens A, Gillam S,. Needs assessment: from theory to practice. Br Med J 1998; 316 (7142): 1448
28. Stevens A, Raftery J, Mant J, Health Care Needs Assessment: The Epidemiologically Based Needs Assessment Reviews. First Series. 2nd ed. Oxon, United Kingdom: Radcliffe Publishing Ltd; 2004
29. Jha V, Garcia-Garcia G, Iseki K, Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382 (9888): 260
30. Global Burden of Disease Study 2010. Global Burden of Disease Study 2010 (GBD 2010) Results by Cause 1990-2010-Country Level. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2013
31. Xu G, Huang T,. Hepatitis B virus-associated glomerular nephritis in East Asia: progress and challenges. Eur J Intern Med 2011; 22 (2): 161
32. Raines N, Gonzalez M, Wyatt C, Risk factors for reduced glomerular filtration rate in a Nicaraguan community affected by Mesoamerican nephropathy. MEDICC Rev 2014; 16 (2): 16
33. Willett WC, Koplan JP, Nugent R, Dusenbury C, Puska P, Gaziano TA,. Prevention of Chronic Disease by Means of Diet and Lifestyle Changes. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, editors. Disease Control Priorities in Developing Countries 2nd ed. Washington (DC): 2006
34. Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GF,. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database Syst Rev 2012; 12: CD004136
35. Mani MK,. Nephrologists sans frontieres: preventing chronic kidney disease on a shoestring. Kidney Int 2006; 70 (5): 821
36. Naicker S,. Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol 2010; 74 (Suppl 1): S13
37. Rizvi SA, Naqvi SA, Zafar MN, Living related renal transplants with lifelong follow-up. A model for the developing world. Clin Nephrol 2010; 74 (Suppl 1): S142